Abstract
Background/Objectives:
This study was aimed to assess the beneficial effects on metabolic syndrome of functional yogurt NY-YP901 (Namyang Dairy Product Co. Ltd and Nutra R&BT Inc., Seoul, Korea) supplemented with mixture of Streptococcus thermophilus, Lactobacillus acidophilus, Bifidobacterium infantis and extra-ingredients containing Bifidobacterium breve (CBG-C2), Enterococcus faecalis FK-23, fibersol-2 and so on.
Subjects/Methods:
This study was designed as an 8-week randomized, double-blind, placebo-controlled, parallel study. Treatment and control groups consumed a functional yogurt NY-YP901 (150 ml) and a placebo yogurt twice a day, respectively, for 8 weeks. Body weight and body mass index (BMI), blood pressure, lipid profiles, fasting glucose with HbA1C and waist circumference were measured before and after treatment. Inclusion criteria were healthy individuals between the ages 20–65 years old who submitted an informed consent.
Results:
During the period August 2009 to December 2009, 101 healthy participants (31 males and 70 females) finished the study. Treatment group were 53 individuals, and the control group were 48 individuals. In the treatment group consuming NY-YP901, statistically significant beneficial changes were observed in body weight (treatment group vs control group=−0.24±1.50 vs +0.64±1.39 kg, P<0.05), BMI (−0.10±0.58 vs +0.24±0.50 kg/m2, P<0.05 ) and low-density lipoprotein (LDL)-cholesterol (−7.71±14.14 vs −0.43±15.32 mg/dl, P<0.05) after 8 weeks. The change in other parameters was not different between the treatment and the control groups.
Conclusions:
The functional yogurt NY-YP901 reduced LDL-cholesterol, body weight and BMI in the subjects at a 300-ml consumption daily for 8 weeks. From these findings, regular intake of functional yogurt NY-YP901 may be consequently related to improve metabolic syndrome.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Agerholm-Larsen L, Raben A, Haulrik N, Hansen AS, Manders M, Astrup A (2000). Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases. Eur J Clin Nutr 54, 288–297.
Blade C, Arola L, Salvado MJ (2010). Hypolipidemic effects of proanthocyanidins and their underlying biochemical and molecular mechanisms. Mol Nutr Food Res 54, 37–59.
Blankson H, Stakkestad JA, Fagertun H, Thom E, Wadstein J, Gudmundsen O (2000). Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr 130, 2943–2948.
Fastinger ND, Karr-Lilienthal LK, Spears JK, Swanson KS, Zinn KE, Nava GM et al. (2008). A novel resistant maltodextrin alters gastrointestinal tolerance factors, fecal characteristics, and fecal microbiota in healthy adult humans. J Am Coll Nutr 27, 356–366.
Frid AH, Nilsson M, Holst JJ, Bjorck IM (2005). Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects. Am J Clin Nutr 82, 69–75.
Goldin BR, Gorbach SL (2008). Clinical indications for probiotics: an overview. Clin Infect Dis 46 (Suppl 2), S96–S100; discussion S144--S151.
Harwood Jr HJ, Chandler CE, Pellarin LD, Bangerter FW, Wilkins RW, Long CA et al. (1993). Pharmacologic consequences of cholesterol absorption inhibition: alteration in cholesterol metabolism and reduction in plasma cholesterol concentration induced by the synthetic saponin beta-tigogenin cellobioside (CP-88818; tiqueside). J Lipid Res 34, 377–395.
Hayakawa K, Kimura M, Kamata K (2002). Mechanism underlying gamma-aminobutyric acid-induced antihypertensive effect in spontaneously hypertensive rats. Eur J Pharmacol 438, 107–113.
Inoue K, Shirai T, Ochiai H, Kasao M, Hayakawa K, Kimura M et al. (2003). Blood-pressure-lowering effect of a novel fermented milk containing gamma-aminobutyric acid (GABA) in mild hypertensives. Eur J Clin Nutr 57, 490–495.
Jauhiainen T, Korpela R (2007). Milk peptides and blood pressure. J Nutr 137, 825S–829S.
Jeon JR, Kim JY (2006). Effects of pine needle extract on differentiation of 3T3-L1 preadipocytes and obesity in high-fat diet fed rats. Biol Pharm Bull 29, 2111–2115.
Kawase M, Hashimoto H, Hosoda M, Morita H, Hosono A (2000). Effect of administration of fermented milk containing whey protein concentrate to rats and healthy men on serum lipids and blood pressure. J Dairy Sci 83, 255–263.
Kennedy A, Martinez K, Schmidt S, Mandrup S, LaPoint K, McIntosh M (2010). Antiobesity mechanisms of action of conjugated linoleic acid. J Nutr Biochem 21, 171–179.
Kim SW, Park SK, Kang SI, Kang HC, Oh HJ, Bae CY et al. (2003). Hypocholesterolemic property of Yucca schidigera and Quillaja saponaria extracts in human body. Arch Pharm Res 26, 1042–1046.
Kim YM, Jeong YK, Wang MH, Lee WY, Rhee HI (2005). Inhibitory effect of pine extract on alpha-glucosidase activity and postprandial hyperglycemia. Nutrition 21, 756–761.
Kishimoto Y, Oga H, Tagami H, Okuma K, Gordon DT (2007). Suppressive effect of resistant maltodextrin on postprandial blood triacylglycerol elevation. Eur J Nutr 46, 133–138.
Le NA, Walter MF (2007). The role of hypertriglyceridemia in atherosclerosis. Curr Atheroscler Rep 9, 110–115.
Lee JS, Ahn KH, Park KJ (2005). Ameliorative effect of pine needle oil on liver protection and lipid metabolism of alcohol fed rats. Food Sci Biotechnol 14 (1), 99–101.
Liong MT (2007). Probiotics: a critical review of their potential role as antihypertensives, immune modulators, hypocholesterolemics, and perimenopausal treatments. Nutr Rev 65, 316–328.
Luhovyy BL, Akhavan T, Anderson GH (2007). Whey proteins in the regulation of food intake and satiety. J Am Coll Nutr 26, 704S–712S.
Lye HS, Kuan CY, Ewe JA, Fung WY, Liong MT (2009). The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin, and phytoestrogens. Int J Mol Sci 10, 3755–3775.
Miguel M, Recio I, Ramos M, Delgado MA, Aleixandre MA (2006). Antihypertensive effect of peptides obtained from Enterococcus faecalis-fermented milk in rats. J Dairy Sci 89, 3352–3359.
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106, 3143–3421.
Okita Y, Nakamura H, Kouda K, Takahashi I, Takaoka T, Kimura M et al. (2009). Effects of vegetable containing gamma-aminobutyric acid on the cardiac autonomic nervous system in healthy young people. J Physiol Anthropol 28, 101–107.
Pereira DI, Gibson GR (2002). Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit Rev Biochem Mol Biol 37, 259–281.
Pfeuffer M, Schrezenmeir J (2007). Milk and the metabolic syndrome. Obes Rev 8, 109–118.
Rapp RJ (2002). Hypertriglyceridemia: a review beyond low-density lipoprotein. Cardiol Rev 10, 163–172.
Seppo L, Jauhiainen T, Poussa T, Korpela R (2003). A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am J Clin Nutr 77, 326–330.
Shimada M, Hasegawa T, Nishimura C, Kan H, Kanno T, Nakamura T et al. (2009). Anti-hypertensive effect of gamma-aminobutyric acid (GABA)-rich Chlorella on high-normal blood pressure and borderline hypertension in placebo-controlled double blind study. Clin Exp Hypertens 31, 342–354.
Xiao JZ, Kondo S, Takahashi N, Miyaji K, Oshida K, Hiramatsu A et al. (2003). Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. J Dairy Sci 86, 2452–2461.
Yim MH, Hong TG, Lee JH (2006). Antioxidant and antimicrobial activities of fermentation and ethanol extracts of pine needles (Pinus densiflora). Food Sci Biotechnol 15, 582–588.
Kishimoto Y, Yoshikawa Y, Miyazato S, Oga H, Yamada T, Tagami H et al. (2009). Effect of resistant maltodextrin on digestion and absorption of lipids. J Health Sci 55, 838–844.
Acknowledgements
This study was supported by Seoul Research and Business Development Program (No. 10582). Namyang Dairy Product Co. Ltd produced and provided the functional yogurt NY-YP901 and the control yogurt for this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Chang, B., Park, S., Jang, Y. et al. Effect of functional yogurt NY-YP901 in improving the trait of metabolic syndrome. Eur J Clin Nutr 65, 1250–1255 (2011). https://doi.org/10.1038/ejcn.2011.115
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2011.115
Keywords
This article is cited by
-
Potential probiotic Lactobacillus delbrueckii subsp. lactis KUMS-Y33 suppresses adipogenesis and promotes osteogenesis in human adipose-derived mesenchymal stem cell
Scientific Reports (2024)
-
The Role of the Microbiome in Erectile Dysfunction
Current Sexual Health Reports (2023)
-
Effect of Lactobacillus on body weight and body fat in overweight subjects: a systematic review of randomized controlled clinical trials
International Journal of Obesity (2017)
-
Kefir drink leads to a similar weight loss, compared with milk, in a dairy-rich non-energy-restricted diet in overweight or obese premenopausal women: a randomized controlled trial
European Journal of Nutrition (2016)
-
Lactobacillus gasseri SBT2055 reduces postprandial and fasting serum non-esterified fatty acid levels in Japanese hypertriacylglycerolemic subjects
Lipids in Health and Disease (2014)